Results for: alcl

BIA-ALCL Special Announcement – May 3, 2019

May 03, 2019

Feature Post Image

Yesterday, the U.S. FDA spelled out the reasons why textured breast implants will remain on the market in the U.S.. Excerpts from the announcement are included below, but first what do we currently know about BIA-ALCL (Breast Implant-Associated Anaplastic Large Cell Lymphoma), and what are these decisions being based upon?

Read More

BIA-ALCL Special Announcement – April 4, 2019

April 04, 2019

Feature Post Image

Special Announcement Regarding Textured Breast Implants From The ISAPS From the ISAPS: We have been informed today that the French health regulatory authorities (ANSM) have announced the following regulations regarding breast implants, and have summarized the most important information for you. You can read the full text of their announcement here. As a precautionary step, […]

Read More

BIA-ALCL Update 2019

February 25, 2019

Feature Post Image

What we know about Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) is evolving. As more cases are identified, we learn more. Right now, there are too few cases to know many of the specifics; however, today II will go over the data currently available

Read More

BIA-ALCL January 2018 Breast Implant Associated Lymphoma Update

January 13, 2018

Feature Post Image

Through the years, I have posted several updates on the rare but very treatable Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on the San Francisco Plastic Surgery Blog. As of January 4, 2018, a pivotal new study was released. The study utilizes 27 years of data from the Netherlands’ Nationwide Network and Registry of Histo- and Cytopathology (PALGA). The key question which the authors tried to answer is, “What are the relative and absolute risks of breast anaplastic large-cell lymphoma (ALCL) in women with breast implants?”

Read More

2017 BI-ALCL Update (Breast Implant Associated – Anaplastic Large Cell Lymphoma)

February 26, 2017

Feature Post Image

It’s been about six months since the last San Francisco Plastic Surgery Blog Breast Implant Associated – Anaplastic Large Cell Lymphoma (BI-ALCL) update. Recently, more information on the subject has become available, and it is about to be published. One article is from the United States, and the other is a global review of what is known to date. Both were recently e-published, ahead of print in the American Society of Plastic Surgeons’ (ASPS) journal, “Plastic and Reconstructive Surgery.” Here are the latest facts…

Read More

ALCL Update – Breast Implants and Anaplastic Large Cell Lymphoma Update

December 03, 2011

Feature Post Image

Earlier this year the San Francisco Plastic Surgery Blog reported an extremely unusual, but possible association between breast implants and a rare form of Non-Hodgkin’s Lymphoma named Anaplastic Large Cell Lymphoma or ALCL. The tumor is extremely rare. Of the 5-10 million women with breast implants fewer than 100 cases have been identified. Literature reviews identified 34 unique cases, and as many as 75 cases may have been identified world wide. Because of the rare nature of the tumor, it is not clear what the association is, if any.

Read More

Breast Implants and Anaplastic Large Cell Lymphoma (ALCL) – Update

April 10, 2011

Late January, 2011, the FDA released a White Paper and Advisory Statement on Anaplastic Large Cell Lymphoma (ALCL) in women with breast implants. It is important that all patients and plastic surgeons understand the current state of knowledge surrounding this condition. Here is a video segment from my appearance on Bay Area’s Local News television station, KRON4.

Read More